Article History
Received: 19 December 2023
Accepted: 24 February 2024
First Online: 21 March 2024
Declarations
:
: Dr. Shimomura reports grants from Chugai Pharmaceutical, Taiho Pharmaceutical, AstraZeneca, Mochida Pharmaceutical, Daiichi Sankyo, Eisai, and Gilead Sciences outside the submitted work, and lecture fees from Chugai Pharmaceutical, Daiichi Sankyo, Eli-Lilly, Kyowa Kirin, AstraZeneca, MSD, Gilead Sciences, Pfizer, Exact Science, and Nihon Medi-Physics outside the submitted work. The other authors declare no potential conflicts of interest.